Fact CheckerSign in

NCT07328061Completed

Virtual Reality for Anxiety and Pain Management in Transvaginal Ultrasound for Endometriosis

Effect of Virtual Reality on Anxiety and Pain During Trans-vaginal Ultrasound for Endometriosis: A Prospective Randomized Controlled Study.

Source: ClinicalTrials.gov · Last updated 8 Jan 2026

Brief summary (registry, in English)

The goal of this study to evaluate whether virtual reality (VR)-based technology, designed to promote relaxation and support pain self-management, can reduce anxiety and pain during trans-vaginal ultrasound (TVUS) for endometriosis. Participants, women undergoing TVUS for endometriosis will be randomly assigned to either VR distraction group (VR-TVUS) or a standard examination group (control). Anxiety and pain levels will be assessed immediately before and after the TVUS.

Status (registry)
Completed
Study type
Interventional
Enrollment
155 (actual)
First submitted
28 Dec 2025
Start date
10 Dec 2023
Primary completion date
20 Aug 2024
Lead sponsor
Sheba Medical Center
NCT number
NCT07328061

What you commit to

  • Study type: Interventional
  • Participants enrolled: 155
  • From 10 Dec 2023 to the primary completion date, 20 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of epilepsy or seizure disorders.
  • History of migraines.
  • Visual or hearing impairment.
  • Diagnosed anxiety disorders.
  • Active respiratory tract infection.

Other

  • Claustrophobia.
  • Current symptoms of dizziness or nausea.
  • Any contraindication to transvaginal ultrasound examination.

Who the study is looking for

  • Women aged 18 to 50 years.
  • Confirmed or suspected diagnosis of endometriosis.
  • Scheduled to undergo transvaginal ultrasound examination.
  • Ability to understand the study procedures and independently complete study questionnaires.
  • Provided written informed consent.

Age in the registry: 18 years to 50 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Endometriosis Center, Sheba Medical Center
Coordinator of this site? Confirm its status
Ramat GanIsraelUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.